![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 4
2022
Burgers, Luisa D.; Li, Yanfen; Michalakis, Stylianos; Ciurus, Sarah; Zahler, Stefan; Mueller, Rolf und Fuerst, Robert
(2022):
The protein biosynthesis inhibitor vioprolide A evokes anti-angiogenic and pro-survival actions by targeting NOP14 and decreasing VEGF receptor 2and TAZ-signaling.
In: Biomedicine & Pharmacotherapy, Bd. 152, 113174
2021
Burgers, Luisa D.; Luong, Betty; Li, Yanfen; Fabritius, Matthias P.; Michalakis, Stylianos; Reichel, Christoph A.; Mueller, Rolf und Fuerst, Robert
(2021):
The natural product vioprolide A exerts anti-inflammatory actions through inhibition of its cellular target NOP14 and downregulation of importin-dependent NF-kappa B p65 nuclear translocation.
In: Biomedicine & Pharmacotherapy, Bd. 144, 112255
Li, Yanfen; Schoen, Christian; Chen, Cheng-Chang; Yang, Zhuo; Liegl, Raffael; Murenu, Elisa; Schworm, Benedikt; Klugbauer, Norbert; Grimm, Christian; Wahl-Schott, Christian; Michalakis, Stylianos und Biel, Martin
(2021):
TPC2 promotes choroidal angiogenesis and inflammation in a mouse model of neovascular age-related macular degeneration.
In: Life Science Alliance, Bd. 4, Nr. 8, e202101047
2020
Chen, Cheng-Chang; Krogsaeter, Einar; Butz, Elisabeth S.; Li, Yanfen; Puertollano, Rosa; Wahl-Schott, Christian; Biel, Martin und Grimm, Christian
(2020):
TRPML2 is an osmo/mechanosensitive cation channel in endolysosomal organelles.
In: Science Advances, Bd. 6, Nr. 46, eabb5064